The Trump Administration Is Deregulating Forever Chemicals
The Breakdown
The U.S. Environmental Protection Agency, under new leadership aligned with industry interests, has accelerated the deregulation of PFAS—or “forever chemicals”—despite intensifying evidence of long-term health risks and mounting public scrutiny. Recent moves include approving PFAS-based pesticides for food crops, relaxing previous reporting requirements, and signaling reduced oversight of products containing these chemicals. These actions are framed as pro-business regulatory reforms, yet they contradict the direction of scientific research, legal precedent, and growing consumer activism.
Analyst View
The chemical sector faces a strategic inflection point: the current deregulatory environment may provide short-term relief from compliance burdens, but it simultaneously heightens longer-term operational and reputational risks. With government agencies rolling back restrictions and requirements for PFAS disclosure, companies may enjoy a temporary competitive reprieve. However, the breadth of ongoing litigation—now tallying nearly 10,000 lawsuits and almost $17 billion in settlements—signals sustained financial exposure beyond regulatory shifts.
Industry lobbying has successfully influenced agency leadership and policy, exemplified by the appointment of several former lobbyists to key EPA roles. Yet, as legal, insurance, and environmental stakeholders intensify scrutiny, the market environment remains volatile. Recent pushback from advocacy groups and the legal system, alongside continued scientific concern, is likely to foster additional waves of litigation and public demand for safer alternatives. Corporate decision-makers must weigh deregulation-driven growth opportunities against shifting customer expectations, marketplace trust, and the persistence of legal risk, all within an accelerating information environment.
Navigating the Signals
For executives in the specialty chemical and materials value chain, the prevailing regulatory relaxation around PFAS does not neutralize market uncertainty. Instead, it amplifies the divergence between short-term market access and long-term exposure across liability, customer trust, and innovation. Decisions made today regarding portfolio composition, investment in non-PFAS alternatives, and proactive engagement with downstream partners will determine the business case for sustainable growth—or future disruption.
Leaders should interrogate whether current product and compliance strategies position their organizations to withstand future regulatory whiplash, stakeholder litigation, and evolving end-market requirements. The most urgent questions: Are we over-exposed to a regulatory regime that could snap back? Have we invested sufficiently in tracking downstream sentiment and alternative material innovation? How robust are our crisis preparedness and value chain communications?
What’s Next?
Breakthrough Marketing Technology partners with senior leadership to anticipate and quantify operational, reputational, and growth risks in specialty chemical markets. We help organizations navigate complexity by providing:
- Real-time monitoring of legislative, regulatory, and legal signals shaping specialty material markets.
- Analysis of downstream value chain sentiment and demand for safer, greener alternatives.
- Executive-ready scenario planning for both rapid regulatory tightening and incremental change.
Don’t wait for market volatility to turn to crisis. Equip your team with the intelligence to make confident, defensible growth decisions in an environment defined by both opportunity and risk.
Source
Understand Your Risk. Seize Your Opportunity.
Take the Breakthrough Market Uncertainty Assessment Guide to pinpoint what’s holding your growth back, and what can accelerate it.
